Why the study?
Fasting prior to percutaneous cardiac procedures is common despite a lack of high-quality evidence regarding the safety of a nonfasting strategy.
Does a nonfasting strategy improve safety outcomes in patients undergoing percutaneous cardiac procedures compared to a fasting strategy?
Does a nonfasting strategy improve safety outcomes in patients undergoing percutaneous cardiac procedures compared to a fasting strategy?
A nonfasting strategy prior to cardiac catheterization with minimal to moderate sedation appears safe, with no significant difference in most adverse events compared to traditional fasting.
Answers are grounded in this paper and cite their sources.
Supports nonfasting before percutaneous cardiac procedures; confirms safety equivalence for nausea, aspiration, AKI, and hypotension.
Fasting prior to percutaneous cardiac procedures is common, despite a lack of high-quality evidence. We conducted a systematic review and meta-analysis to assess the safety of a nonfasting strategy. Online databases Medline, Cochrane CENTRAL, and Google Scholar were searched. Quantitative analysis was performed using R software (Version 4.1.2) with meta package. Analyzed outcomes included nausea, vomiting, aspiration, intubation, hypoglycemia, hypotension, acute kidney injury, patient satisfaction score, and length of hospital stay. Eight randomized controlled trials were included with 3,382 patients. There was no significant difference between fasting and nonfasting for nausea/vomiting odds ratio (OR) 0.99 (95% CI, 0.68-1.45), hypoglycemia OR 1.28 (95% CI, 0.75-2.18), aspiration OR 0.72 (95% CI, 0.36-1.43), acute kidney injury OR 0.69 (95% CI, 0.38-1.23), and hypotension OR 1.57 (95% CI, 0.47-5.30). No patient in either group underwent endotracheal intubation. Additionally, there was no difference in patient satisfaction score and length of hospital stay with a standardized mean difference (SMD) of 0.23 (95% CI, -0.62 to 1.07) and 0.0 (95% CI, -0.6 to 0.7) respectively. Sub-group analysis, however, showed increased odds of nausea/vomiting in the fasting group compared to nonfasting OR 1.20 (95% CI, 1.04-1.39) and decreased odds of acute kidney injury in fasting compared to nonfasting group OR 0.50 (95% CI, 0.28-0.89). In conclusion, this analysis shows no significant difference in most safety outcomes between a fasting and a nonfasting strategy with potential increase in nausea/vomiting and decrease in acute kidney injury with fasting. More studies are needed to better understand these differences.
No takes yet. Share an insight, caveat, or question.
Pir et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: